FinTechFunding

Medlab Clinical: Recieves Australian patent for NanoCelle

  • Biotech company Medlab Clinical (MDC) has been granted an Australian patent for its NanoCelle delivery platform
  • Essentially, NanoCelle delivers drug formulations via an oral spray
  • So far, product testing results have indicated the spray can lead to better absorption of the drugs, helping the formulation avoid ingested routes
  • It can also potentially lower drug dosages and reduce the side effects of some formulations
  • Medlab has also filed patent applications in other jurisdictions, such as the U.S., Europe and New Zealand
  • On the market this afternoon, Medlab is up 3.03 per cent, trading for 17 cents per share
Previous article
Xantippe Resources: Receives preliminary results from Southern Cross drilling
Next article
Argonaut Resources: Raises $2.7M for copper exploration
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Stablecoins Gain Traction in B2B Payments

Growing interest shows potential for stablecoins in business transactions.Highlights: Stablecoins are becoming popular for business-to-business transactions.They provide improved...
FinTech

Paysend Raises $25 Million, Strengthening Expansion Plans

This new funding round aims to boost Paysend's global reach and service offerings.Highlights: Paysend secures $25 million in...
FinTech

Lloyds Tests Quantum Computing to Strengthen Fraud Detection

The bank explores advanced tech to tackle money mule networks effectively.Highlights: Lloyds is experimenting with quantum computing for...
FinTech

9fin Secures $170 Million Raise, Valued at $1.3 Billion

The fintech platform enhances its funding to accelerate growth and innovation.Highlights: 9fin raised $170 million in a recent...